share_log

大洋生物(003017.SZ):2024年员工持股计划非交易过户完成

Zhejiang Dayang Biotech Group (003017.SZ): The employee stock ownership plan for 2024 has been completed without any trade transfers.

Gelonghui Finance ·  Sep 10 03:46

Gelonghui, September 10, 丨 Ocean Biotech (003017.SZ) announced that on September 10, 2024, the company received the “Securities Transfer Registration Confirmation” issued by the Shenzhen branch of China Securities Registration and Settlement Co., Ltd., and 1,947,030 shares of the company's shares held by the “Zhejiang Dayang Biotechnology Group Co., Ltd. Repurchase Special Securities Account” were transferred untraded to the “Zhejiang Dayang Biotechnology Group Co., Ltd. - 2024 Employee Stock Ownership Plan” account. The number of shares transferred accounted for 2.32% of the company's total share capital. There is no difference between the number of non-transactional shares transferred through the current employee shareholding plan and the plan reviewed and approved by the shareholders' meeting. After the implementation of the current employee shareholding plan, the total share of the company's active employee shareholding plan shall not exceed 10% of the company's total share capital, and the number of underlying shares corresponding to the employee shareholding plan share held by any holder shall not exceed 1% of the company's total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment